AbbVie’s purchase of the cancer fighting startup backed by Peter Thiel’s Founders Fund bodes well for biotech funding.
Customized, printed orthopedic implants could be the future. In the meantime, the new manufacturing method is helping companies cut costs.
Study of exceptionally healthy old people fails to trace their well-being to specific genes.
Uncertainty about future regulations clouds the future of agricultural biotechnology in the U.S.
Complexity theorists and biologists reveal how benefits spread super-exponentially through populations.
New foods like a mushroom altered with CRISPR gene editing are falling outside the purview of regulators.
Yellow fever has already killed hundreds in two African countries, and health officials fear it could spread further.
Researchers used a brain-computer interface to give a man control over his paralyzed hand.
A Facebook billionaire makes a major investment in immunotherapy.
A genetic technology that can kill off mosquito species could eradicate malaria. But is it too risky to ever use?